Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
56.5%
% of XDNA's 23 holdings also in GNOM
31.7%
% of GNOM's 41 holdings also in XDNA
Overlap by Weight
Sector Drift (XDNA minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XDNA |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
CRISPR THERAPEUTICS AG | 15.1% | 5.8% | 5.8% |
|
INTELLIA THERAPEUTICS, INC. | 8.7% | 4.0% | 4.0% |
|
BEAM THERAPEUTICS, INC. | 13.7% | 3.6% | 3.6% |
|
AGILENT TECHNOLOGIES INC | 2.7% | 3.9% | 2.7% |
|
EDITAS MEDICINE, INC. | 5.7% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
XDNA Overweight Relative to GNOM
|
BEAM THERAPEUTICS, INC. | 10.1% |
|
THERMO FISHER SCIENTIFIC INC | 9.5% |
|
CRISPR THERAPEUTICS AG | 9.3% |
|
PRIME MEDICINE, INC. | 5.9% |
|
INTELLIA THERAPEUTICS, INC. | 4.7% |
|
EDITAS MEDICINE, INC. | 4.2% |
|
CARIBOU BIOSCIENCES, INC. | 3.9% |
|
ABBVIE INC | 3.8% |
|
POSEIDA THERAPEUTICS, INC. | 3.8% |
|
VERVE THERAPEUTICS, INC. | 3.6% |
XDNA Underweight Relative to GNOM
 |
ENI SPA-SPONSORED ADR | -7.5% |
|
NATERA INC | -4.4% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.9% |
|
10X GENOMICS INC CLASS A | -3.8% |
|
ULTRAGENYX PHARMACEUTICAL IN | -3.8% |
 |
GENSCRIPT BIOTECH CORPORATION | -3.7% |
|
PACIFIC BIOSCIENCES OF CALIF | -3.7% |
|
BIOMARIN PHARMACEUTICAL INC | -3.5% |
|
VERACYTE INC | -3.4% |
|
BIO-TECHNE CORPORATION | -3.4% |